CD4 and neoplasm: Alternatively, a conventional naïve CD4+ T cell may encounter a tumor-associated (‘self’) or tumor-specific (‘neo’) antigen in the tumor environment, become activated, and under the influence of an immunosuppressive tumor microenvironment, differentiate into an induced FOXP3+ (‘iTreg’) [3].